2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
Playback speed
10 seconds
ASCO® 2024 Insights: "Study EV-103 - Neoadjuvant Enfortumab Vedotin in Cisplatin-Ineligible MIBC Patients"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Nataliya Mar
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Nataliya Mar
138 views
June 21, 2024
Comments 0
Login to view comments.
Click here to Login
GU